Risk Assessment for Anti-Infectives-Related Acute Kidney Injury Using the Japanese Adverse Drug Event Report Database

Background: Acute kidney injury (AKI) is associated with significant increases in short- and long-term morbidity and mortality. Drug-induced AKI is a major concern in the present healthcare system. Our spontaneous reporting system (SRS) analysis assessed links between AKIs, along with patients’ age, as healthcare-associated risks and administered anti-infectives. We also generated anti-infectives-related AKI-onset profiles.Method: We calculated adjusted reporting odds ratios (RORs) for reports of anti-infectives-related AKIs (per Medical Dictionary for Regulatory Activities) in the Japanese Adverse Drug Event Report database and evaluated associations between anti-infectives and age by association rule mining. We evaluated time-to-onset data and hazard types using the Weibull parameter.Results: Among 534,688 reports (submission period: April 2004–June 2018), there were 21,727 AKI events. Anti-infective treatments including glycopeptide antibacterials, fluoroquinolones, third-generation cephalosporins, triazole derivatives, and carbapenems were associated with 596, 494, 341, 315, and 313 AKI incidences, respectively. Adjusted RORs of anti-infectives-related AKIs increased among older patients and were higher in anti-infective combination therapies [anti-infectives, ≥ 2; ROR, 2.75 (2.56–2.95)] than in monotherapies [ROR, 1.52 (1.45–1.61)]. In association rule mining, the number of anti-infectives and age were associated with anti-infectives-related AKI lift values (as consequent). Moreover, 48.1% of AKIs occurred within 5 days (median, 5.0 days) of anti-infective therapy initiation.Conclusion: Thus, adjusted RORs derived from our new SRS analysis indicate potential AKI risks linked to age and number of administered anti-infectives.

[1]  M. Miyazaki,et al.  Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database , 2020, BMC Pharmacology and Toxicology.

[2]  Kenichiro Sato,et al.  Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database , 2019, Journal of Neuro-Oncology.

[3]  Yumi Motooka,et al.  Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database , 2018, Journal of pharmaceutical health care and sciences.

[4]  J. Kellum,et al.  Drug‐Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database , 2018, Pharmacotherapy.

[5]  Licong Cui,et al.  Query-constraint-based mining of association rules for exploratory analysis of clinical datasets in the National Sleep Research Resource , 2018, BMC Medical Informatics and Decision Making.

[6]  Raymond K. Hsu,et al.  Management of Acute Kidney Injury: Core Curriculum 2018. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  Yumi Motooka,et al.  Analysis of polypharmacy effects in older patients using Japanese Adverse Drug Event Report database , 2017, PloS one.

[8]  Y. Kinosada,et al.  Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events , 2016, PloS one.

[9]  H. Yamada,et al.  A Pharmacovigilance Approach for Post-Marketing in Japan Using the Japanese Adverse Drug Event Report (JADER) Database and Association Analysis , 2016, PloS one.

[10]  P. Yildirim,et al.  Association Patterns in Open Data to Explore Ciprofloxacin Adverse Events , 2015, Applied Clinical Informatics.

[11]  Y. Kinosada,et al.  Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database. , 2015, Biological & pharmaceutical bulletin.

[12]  Y. Kinosada,et al.  Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports , 2015, Journal of pharmaceutical health care and sciences.

[13]  J. Li,et al.  Preliminary Clinical Study of the Effect of Ascorbic Acid on Colistin-Associated Nephrotoxicity , 2015, Antimicrobial Agents and Chemotherapy.

[14]  M. Molokhia,et al.  Illustration of the Weibull Shape Parameter Signal Detection Tool Using Electronic Healthcare Record Data , 2013, Drug Safety.

[15]  Mahboob Rahman,et al.  Acute kidney injury: a guide to diagnosis and management. , 2012, American family physician.

[16]  Fabrizio De Ponti,et al.  Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) , 2012 .

[17]  P Ryan,et al.  Novel Data‐Mining Methodologies for Adverse Drug Event Discovery and Analysis , 2012, Clinical pharmacology and therapeutics.

[18]  Carol Friedman,et al.  Mining multi-item drug adverse effect associations in spontaneous reporting systems , 2010, BMC Bioinformatics.

[19]  S. Anderson,et al.  The aging kidney: physiological changes. , 2010, Advances in chronic kidney disease.

[20]  M. Rosner,et al.  Acute kidney injury. , 2009, Current drug targets.

[21]  R. Laniado-Laborín,et al.  Amphotericin B: side effects and toxicity. , 2009, Revista iberoamericana de micologia.

[22]  Emily R. Hajjar,et al.  Polypharmacy in elderly patients. , 2007, The American journal of geriatric pharmacotherapy.

[23]  E. Eldesoky,et al.  Pharmacokinetic-Pharmacodynamic Crisis in the Elderly , 2007, American journal of therapeutics.

[24]  Kurt Hornik,et al.  Introduction to arules – A computational environment for mining association rules and frequent item sets , 2009 .

[25]  J. Gurwitz.  Polypharmacy: a new paradigm for quality drug therapy in the elderly? , 2004, Archives of internal medicine.

[26]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[27]  A. Egberts,et al.  Detecting drug–drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs , 2000, European Journal of Clinical Pharmacology.

[28]  M. Rybak,et al.  Nephrotoxicity of vancomycin, alone and with an aminoglycoside. , 1990, The Journal of antimicrobial chemotherapy.

[29]  H D Humes,et al.  Drug-induced nephrotoxicity. , 1982, Disease-a-month : DM.

[30]  Soulaymani Abdelmajid,et al.  Use of measures of disproportionality in pharmacovigilance , 2016 .

[31]  M. Kargar,et al.  Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome. , 2013, Acta medica Iranica.

[32]  Tze-Yun Leong,et al.  Automated Knowledge Extraction for Decision Model Construction: A Data Mining Approach , 2003, AMIA.

[33]  Sergio A. Alvarez,et al.  Chi-squared computation for association rules: preliminary results , 2003 .

[34]  M. Lindquist,et al.  A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions , 2002, Pharmacoepidemiology and drug safety.

[35]  R. Agarwal.  Fast Algorithms for Mining Association Rules , 1994, VLDB 1994.